Try the modernized beta website. Learn more about the modernization effort.

Key Record Dates Identifier: NCT03249792
Brief Title: Study of MK-2118 Administered as Intratumoral Injection as Monotherapy and in Combination With Pembrolizumab (MK-3475) or by Subcutaneous Injection in Combination With Pembrolizumab in the Treatment of Adults With Advanced/Metastatic Solid Tumors or Lymphomas (MK-2118-001)

First Submitted : August 9, 2017
First Submitted that Met QC Criteria : August 11, 2017
First Posted : August 15, 2017

Last Update Submitted that Met QC Criteria : August 20, 2021
Last Update Posted : August 23, 2021